Rights Commence Trading

Imagion Biosystems Limited (ASX: IBX) (the Company), is pleased to confirm that the rights associated with the Company’s Renounceable Rights Issue announced…


Appendix 4C - Quarterly

Imagion Biosystems has released its Quarterly Cashflow Report for the period ending 30 September 2019. Read Appendix 4C.